Open Access

Ranga Yogeshwar

• Orešković and Porsdam Mann draw a distinction between ‘fast’ and ‘slow’ science. Whereas the latter involves rigorous and laborious adherence to the scientific method, the former represents the reality that much scientific work faces time pressures which at times force shortcuts. The distinction can be seen to operate in contemporary research into the coronavirus pandemic: whereas the development of vaccines and treatments usually requires years of meticulous laboratory work and several more years of clinical testing, the many millions suffering from the disease need a treatment now. However, by taking too many safeguards off the treatment discovery and testing pipelines, or by refusing to act in accordance with scientific advice, governments risk sacrificing the public’s trust not only in the government’s scientific bona fides but in the scientific process itself. This is a heavy price to pay, argue Orešković and Porsdam Mann, and point to evidence indicating that the success of Germany and Japan in combating COVID-19 can be traced to public trust in science and government, as well as scientifically-informed and respectful national leadership.